Wim Ottevaere
Director/Board Member chez SEQUANA MEDICAL N.V.
Profil
Wim Ottevaere is an Independent Non-Executive Director at Sequana Medical NV.
He previously worked as a Finance Director at Vanhout & Fils NV from 1990 to 1992, and as a Chief Financial Officer at Fujirebio Europe NV from 1992 to 2006 and at Fujirebio US, Inc. from 1992 to 2006.
He also served as the Chief Financial Officer at Ablynx NV from 2006 to 2018.
Ottevaere is a graduate of the University of Antwerp.
Currently, he is also the Chief Financial Officer at Biotalys NV, a position he has held since 2018 and will hold until 2023.
Postes actifs de Wim Ottevaere
| Sociétés | Poste | Début |
|---|---|---|
| SEQUANA MEDICAL N.V. | Director/Board Member | 08/11/2018 |
Anciens postes connus de Wim Ottevaere
| Sociétés | Poste | Fin |
|---|---|---|
| BIOTALYS NV | Director of Finance/CFO | 01/07/2023 |
| ABLYNX | Director of Finance/CFO | 01/09/2018 |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Director of Finance/CFO | 01/07/2006 |
| Fujirebio US, Inc. | Director of Finance/CFO | 01/01/2006 |
Vanhout & Fils NV
 Vanhout & Fils NV HomebuildingConsumer Durables Part of Van Roey SA NV, Vanhout & Fils NV provides building and structural construction services. The private company is based in Geel, Belgium. | Director of Finance/CFO | 01/01/1992 |
Formation de Wim Ottevaere
| University of Antwerp | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOTALYS NV | Process Industries |
| SEQUANA MEDICAL N.V. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Health Technology |
Vanhout & Fils NV
Vanhout & Fils NV HomebuildingConsumer Durables Part of Van Roey SA NV, Vanhout & Fils NV provides building and structural construction services. The private company is based in Geel, Belgium. | Consumer Durables |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
| Fujirebio US, Inc. |
